Acorda Therapeutics Inc. (ACOR)
NASDAQ: ACOR
· Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM
Acorda Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -263.43M | -252.85M | -15.95M | -20.92M | -58.22M | -65.92M | -105.63M | -118.84M | -95.03M | -103.95M | -166.44M | -132.02M | -126.57M |
Depreciation & Amortization | 24.64M | 31.67M | 31.78M | 31.66M | 32.19M | 32.81M | 33.24M | 33.77M | 33.96M | 33.95M | 35.86M | 37.78M | 39.75M |
Stock-Based Compensation | 537K | 478K | 513K | 736K | 1.08M | 1.49M | 1.8M | 2.29M | 2.77M | 3M | 4.1M | 5.73M | 6.83M |
Other Working Capital | -6.07M | -5.37M | -3.69M | 1.85M | 2.42M | 676K | 10.24M | 10.13M | 11.12M | 12.78M | 16.59M | 15.08M | 15.74M |
Other Non-Cash Items | 268.93M | 260.73M | -11.68M | -11.84M | -16.44M | -21.68M | 4.07M | 7.66M | 3.5M | 5.91M | 61.32M | 30.68M | 22.11M |
Deferred Income Tax | -41.14M | -43.18M | -2.65M | -218K | 28.37M | 30.67M | 29.9M | 25.38M | -1.78M | -5.19M | -10.92M | -6.39M | -5.28M |
Change in Working Capital | -16.69M | -10.83M | -3.91M | -10.77M | -1.29M | 1.7M | 9.87M | 15.82M | 28.47M | 24.93M | 32.94M | 27.18M | 14.05M |
Operating Cash Flow | -27.15M | -13.98M | -1.9M | -11.35M | -14.3M | -20.92M | -26.75M | -33.92M | -28.1M | -41.35M | -43.14M | -37.03M | -49.12M |
Capital Expenditures | -264K | -264K | -206K | -136K | -206K | -245K | -260K | -110K | -176K | -191K | -506K | -358K | -2.2M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.33M | 25.34M | 50.46M |
Other Investing Acitivies | n/a | n/a | 109K | -14K | -14K | -14K | 73.85M | 73.97M | 73.97M | 73.97M | n/a | n/a | n/a |
Investing Cash Flow | -264K | -264K | -97K | -27K | -97K | -136K | 73.71M | 73.86M | 73.79M | 73.78M | 4.83M | 24.98M | 48.26M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.88M | 6.88M | n/a | -1K | -1K | -1K | -73.97M | -73.97M | -142.97M | -69.66M | 4.91M | 4.82M | 73.82M |
Financial Cash Flow | n/a | n/a | -6.88M | n/a | n/a | n/a | -73.97M | -73.97M | -142.97M | -69.66M | 3.12M | 3.03M | 72.03M |
Net Cash Flow | -27.42M | -14.06M | -599K | -10.14M | -13.7M | -20.55M | -27.74M | -34.5M | -96.98M | -37.67M | -34.01M | -7.41M | 72.57M |
Free Cash Flow | -27.41M | -14.25M | -2.11M | -11.48M | -14.51M | -21.17M | -27.01M | -34.03M | -28.27M | -41.54M | -43.65M | -37.39M | -51.31M |